Post-emergency Management of Patients With Transient Ischemic Attack

NCT ID: NCT06170034

Last Updated: 2025-01-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

49 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-16

Study Completion Date

2024-06-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A transient ischemic attack (TIA) is a momentary neurological dysfunction due to a brief cessation of blood flow to a region of the brain, resulting in typical signs of stroke (hemiplegia, aphasia, dysarthria), but whose clinical symptoms typically last less than an hour, with no visible lesion on imaging. This diagnosis remains difficult and is essentially based on the clinical judgment of the physician.

Because a TIA can be a "pre-alarm" for stroke in 20-30% of cases, it needs to be treated appropriately and as early as possible in the emergency department. Stroke rates after untreated TIA are 5% within 48 hours, 10% within one month and 20% within one year. This risk is calculated using the ABCD² score which is based on the patient's risk factors and the clinical manifestations of TIA. Patients with a score ≥ 3 should be hospitalized as soon as possible for a complete medical evaluation. However, this score has not been scientifically validated, and several specialists agree that all TIAs should be evaluated immediately. Preventing stroke is a major public health issue because it is a serious, disabling and sometimes fatal disease. Given the seriousness of the progression from TIA to stroke, the French National Authority for Health has issued a series of management recommendations. However, in practice, these guidelines remain complicated to follow and patients management may vary and be more or less effective.

Therefore, the aim of this study is to highlight the differences in how inpatients and outpatients are managed. Following these observations, solutions will be sought to make the care and management of these patients more efficient and more in line with recommendations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transient Ischemic Attack

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TIA patients

Satisfaction questionnaire

Intervention Type BEHAVIORAL

Satisfaction questionnaire to assess how TIA patients feels about their medical care.

Medical care questionnaire

Intervention Type OTHER

Recording appointments and results of examinations and consultations in TIA management

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Satisfaction questionnaire

Satisfaction questionnaire to assess how TIA patients feels about their medical care.

Intervention Type BEHAVIORAL

Medical care questionnaire

Recording appointments and results of examinations and consultations in TIA management

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18 years old.
* Consultation in the emergency department.
* Suspected TIA diagnosed by emergency physician.
* Duration of TIA symptoms \<1 hour.

Exclusion Criteria

* Validation MRI performed prior to suspected TIA.
* Patient hospitalized for a condition other than TIA, including stroke.
* Patient referred to another hospital for further examination.
* Pregnant women.
* Patient unable to understand and answer a questionnaire.
* Patient under legal protection.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Henri Duffaut - Avignon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yohan Fouilhe, Medical Intern

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier d'Avignon, Service des urgences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier d'Avignon

Avignon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEC AIT 84

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Minor Stroke Therapy Evaluation
NCT03796468 RECRUITING NA
Reducing Risk of Recurrence
NCT01122394 COMPLETED NA
Lleida TIA Intervention Study
NCT04524078 COMPLETED NA